Home/Annexin Pharmaceuticals/Anna Frostegård
AF

Anna Frostegård

Chief Scientific Officer / Chief Medical Officer (CSO/CMO)

Annexin Pharmaceuticals

Annexin Pharmaceuticals Pipeline

DrugIndicationPhase
ANXVRetinal Vein Occlusion (RVO)Phase 2a